A nurse working on a surgical unit is developing a care plan for a client who has paraplegia. The client has an area of nonblanchable erythema over his ischium. Which of the following interventions should the nurse include in the care plan?

Choice A reason: Fibromyalgia, a chronic pain condition, is not a contraindication for oral contraceptives. Estrogen and progesterone do not exacerbate fibromyalgia’s musculoskeletal or neurological symptoms, as they primarily affect hormonal pathways, making contraceptives safe for use in clients with this condition.
Choice B reason: Hypertension is a contraindication for oral contraceptives, as estrogen increases renin-angiotensin activity, elevating blood pressure. This risks cardiovascular events like stroke or myocardial infarction, especially in clients with existing hypertension, necessitating alternative contraception to avoid vascular complications.
Choice C reason: Iron-deficiency anemia is not a contraindication, as oral contraceptives may reduce menstrual bleeding, improving anemia by decreasing iron loss. Their hormonal effects do not impact erythropoiesis, making them potentially beneficial for anemic clients, unlike hypertension, which poses risks.
Choice D reason: Human papillomavirus (HPV) is not a contraindication, as it affects cervical epithelium, not hormonal pathways. While some studies suggest a weak link to cervical cancer, HPV vaccination and screening mitigate risks, making oral contraceptives safe for clients with HPV.

Choice A reason: Using two identifiers (e.g., name and medical record number) ensures the correct client receives the medication, preventing errors. This aligns with safety protocols, reducing risks of administering drugs to the wrong person. Verification confirms identity before administration, safeguarding against adverse events and ensuring compliance with standards like The Joint Commission.
Choice B reason: Checking the medication label twice is part of the “rights” of administration but is less specific than using two identifiers for client verification. While important, it addresses medication accuracy, not client identity, which is the primary safety concern to prevent errors, making it less critical in this context.
Choice C reason: Administering medication within 3 hours of the scheduled time relates to timing protocols, not the core action of ensuring safe administration. While timely administration is important, verifying client identity is the priority to prevent errors, as incorrect patient identification can lead to severe adverse events, making this less relevant.
Choice D reason: Administering medications to treat a condition to the actual prescriptions is vague and not a standard safety action. The focus is on verifying client identity and medication accuracy, not a general treatment alignment. This statement does not address a specific, actionable step in safe medication administration, making it incorrect.